BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30767060)

  • 21. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Petri H; Ahtarovski KA; Vejlstrup N; Vissing J; Witting N; Køber L; Bundgaard H
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):59. PubMed ID: 25086734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance.
    Altiok E; Tiemann S; Becker M; Koos R; Zwicker C; Schroeder J; Kraemer N; Schoth F; Adam D; Friedman Z; Marx N; Hoffmann R
    J Am Soc Echocardiogr; 2014 Mar; 27(3):249-57. PubMed ID: 24368027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.
    Rosales XQ; Moser SJ; Tran T; McCarthy B; Dunn N; Habib P; Simonetti OP; Mendell JR; Raman SV
    J Cardiovasc Magn Reson; 2011 Aug; 13(1):39. PubMed ID: 21816046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.
    Lang SM; Shugh S; Mazur W; Sticka JJ; Rattan MS; Jefferies JL; Taylor MD
    Pediatr Cardiol; 2015 Oct; 36(7):1495-501. PubMed ID: 25976773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive myocardial injury in myotonic dystrophy type II and facioscapulohumeral muscular dystrophy 1: a cardiovascular magnetic resonance follow-up study.
    Blaszczyk E; Lim C; Kellman P; Schmacht L; Gröschel J; Spuler S; Schulz-Menger J
    J Cardiovasc Magn Reson; 2021 Nov; 23(1):130. PubMed ID: 34743704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
    Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Prognostic Impact of Septal Late Gadolinium Enhancement in Acute Myocarditis With or Without Preserved Left Ventricular Function.
    Imazio M; Angelico G; Andriani M; Lobetti-Bodoni L; Davini O; Giustetto C; Rinaldi M
    Am J Cardiol; 2018 Dec; 122(11):1955-1958. PubMed ID: 30266253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional myocardial strain by cardiac magnetic resonance feature tracking for detection of scar in ischemic heart disease.
    Stathogiannis K; Mor-Avi V; Rashedi N; Lang RM; Patel AR
    Magn Reson Imaging; 2020 May; 68():190-196. PubMed ID: 32084516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Myocardial Fibrosis on Left Ventricular Function Evaluated by Feature-Tracking Myocardial Strain Cardiac Magnetic Resonance in Competitive Male Triathletes With Normal Ejection Fraction.
    Tahir E; Starekova J; Muellerleile K; Freiwald E; von Stritzky A; Münch J; Avanesov M; Weinrich JM; Stehning C; Cavus E; Bohnen S; Radunski UK; Blankenberg S; Adam G; Simon P; Pressler A; Patten M; Lund GK
    Circ J; 2019 Jun; 83(7):1553-1562. PubMed ID: 31080228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pivotal role of cardiovascular imaging in the identification and risk stratification of non-compaction cardiomyopathy patients.
    Mavrogeni SI; Markousis-Mavrogenis G; Vartela V; Manolopoulou D; Abate E; Hamadanchi A; Rigopoulos AG; Kolovou G; Noutsias M
    Heart Fail Rev; 2020 Nov; 25(6):1007-1015. PubMed ID: 31784859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study.
    Smith GC; Kinali M; Prasad SK; Bonne G; Muntoni F; Pennell DJ; Nihoyannopoulos P
    J Cardiovasc Magn Reson; 2006; 8(5):723-30. PubMed ID: 16891232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
    Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
    Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late gadolinium enhancement in Brugada syndrome: A marker for subtle underlying cardiomyopathy?
    Bastiaenen R; Cox AT; Castelletti S; Wijeyeratne YD; Colbeck N; Pakroo N; Ahmed H; Bunce N; Anderson L; Moon JC; Prasad S; Sharma S; Behr ER
    Heart Rhythm; 2017 Apr; 14(4):583-589. PubMed ID: 27919765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
    Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of left ventricular late gadolinium enhancement with left atrial low voltage areas in patients with atrial fibrillation.
    Stegmann C; Jahnke C; Paetsch I; Hilbert S; Arya A; Bollmann A; Hindricks G; Sommer P
    Europace; 2018 Oct; 20(10):1606-1611. PubMed ID: 29420707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.